Gene Logic will pay recently appointed CEO and president Charles Dimmler $425,000 in salary plus an incentive package worth as much as 40 percent of his salary.
The company also gave Dimmler an option to buy as much as 120,000 shares of the company’s common stock at $1.37 per share that will vest in four increments spread out over three years, as well as a total of 130,000 shares as bonuses if the company achieves milestones.
Joanne Smith-Farrell has resigned from Gene Logic as senior vice president of business development and licensing, according to a filing with the Securities and Exchange Commission. Farrell will leave her post on July 31.
Douglas Williams has been named president of Zymogenetics, and Bruce Carter will relinquish that post but will continue as CEO and chairman of the board, the company said.
James Johnson has been named executive vice president and will remain in his roles as CFO and treasurer. The company also has promoted Darren Hanby to senior vice president. All of the promotions took effect July 1, the company said.
Sequenom has appointed Richard Lerner to its board of directors. Lerner is president of the Scripps Research Institute, a professor of immunochemistry, and is a member of the Skaggs Institute for Chemical Biology at Scripps. Lerner also serves on the boards at Kraft and Opko.
ForteBio has named Katherine Flagg vice president of sales. In the job, Flagg will be responsible for product distribution in Europe, Asia, and in other regions. Flagg previously was vice president of business development at Rapid Micro Biosystems.
GeneLink said this week it has named Bernard Kasten executive chairman of the board. Kasten formerly was a scientific adviser for GeneLink, and chief laboratory office for Quest Diagnostics.
Kasten also was CEO of SIGA Technologies and he is chairman of Cleveland BioLabs.
Robert Palazzo has taken over as president of the Federation of American Societies for Experimental Biology last week. Palazzo, who is provost of Rensselaer Polytechnic Institute, is founding director of the Center for Biotechnology and Interdisciplinary Studies.
Cold Spring Harbor Laboratory has appointed five members to an advisory committee for its new Quantitative Imaging Cytometry Center. Members include: Zbigniew Darzynkiewicz, director of the Brander Cancer Research Institute, New York Medical College, Valhalla, NY; William Geddie, an assistant professor at the University of Toronto’s Department of Pathology, University Health Network; James Jacobberger, an oncology professor and director of shares resources at the Case Comprehensive Cancer Center; Amgen senior scientist Gloria Juan; and William Telford, director of the National Cancer Institute’s Core Flow Cytometry Center.
Expression Analysis has brought in Anne Pontius to be the company’s senior director of Quality Systems. Pontius will be responsible for regulatory compliance and quality assurance programs at the company’s testing facility. She recently was president and principal consultant for Laboratory Compliance Consultants, and currently is president elect of the Clinical Laboratory Management Association.
Epidauros has named Dagmar Kasper to be vice president of business development and marketing, and Elke Roschmann to the post of head of strategic development and licensing.
Kasper was formerly with Nordic Bioscience’s sales and marketing department and was a general manager at the company, and Roschmann formerly was in senior positions at Amersham Pharmacia, and at Integragen.
Sigma-Aldrich has promoted Gerrit van den Dool to the job of vice president of sales, and has named David Smoller to be president of the company’s Research Biotech business unit. Van den Dool has been with Sigma-Aldrich since 1999 and Smoller started as Sigma’s vice president of research and development in 2004.
Ciphergen has elected Michael Callaghan, Kenneth Conway, and James Rathmann to three-year terms as Class I directors.
Thermo Fisher Scientific has named Michael Bell and Stephen Kaufman to the company’s board. Bell is one of the managing directors of Monitor Clipper Partners, and Kaufman is a senior lecturer of business administration at the Harvard Business School.
Maynard Olson has won the $500,000 Gruber Genetics Prize from the Peter Gruber Foundation, which honors scientists who make contributions to the genetics field. Olson is a genomics professor at the University of Washington, a key contributor to the Human Genome Project, and he currently is studying the bacterium that causes cystic fibrosis.